Patents by Inventor Huihui Kong

Huihui Kong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VECTORS FOR ELICITING IMMUNE RESPONSES TO NON-DOMINANT EPITOPES IN THE HEMAGGLUTININ (HA) PROTEIN
    Publication number: 20230190913
    Abstract: Methods of preparing influenza viruses having altered immunodominant epitopes in HA, e.g., having one or more residues in one or more of antigenic sites A-E in HA altered, and viral vectors, e.g., influenza virus VLPs or non-influenza viruses or VLPs thereof expressing or having influenza HAs with altered immunogenicity as a result of altered immunodominant epitopes therein are provided.
    Type: Application
    Filed: July 18, 2022
    Publication date: June 22, 2023
    Inventors: Yoshihiro Kawaoka, Gabriele Neumann, Huihui Kong
  • Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
    Patent number: 11389523
    Abstract: Methods of preparing influenza viruses having altered immunodominant epitopes in HA, e.g., having one or more residues in one or more of antigenic sites A-E in HA altered, and viral vectors, e.g., influenza virus VLPs or non-influenza viruses or VLPs thereof expressing or having influenza HAs with altered immunogenicity as a result of altered immunodominant epitopes therein are provided.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: July 19, 2022
    Assignee: Wisconsin Alumni Research Foundation (WARF)
    Inventors: Yoshihiro Kawaoka, Gabriele Neumann, Huihui Kong
  • VECTORS FOR ELICITING IMMUNE RESPONSES TO NON-DOMINANT EPITOPES IN THE HEMAGGLUTININ (HA) PROTEIN
    Publication number: 20200188506
    Abstract: Methods of preparing influenza viruses having altered immunodominant epitopes in HA, e.g., having one or more residues in one or more of antigenic sites A-E in HA altered, and viral vectors, e.g., influenza virus VLPs or non-influenza viruses or VLPs thereof expressing or having influenza HAs with altered immunogenicity as a result of altered immunodominant epitopes therein are provided.
    Type: Application
    Filed: August 20, 2019
    Publication date: June 18, 2020
    Inventors: Yoshihiro Kawaoka, Gabriele Neumann, Huihui Kong